Biochemical peculiarities and drug targets in Cryptosporidium parvum: lessons from other coccidian parasites (Q33687965)

28 July 2017

1 reference

title

Biochemical peculiarities and drug targets in Cryptosporidium parvum: lessons from other coccidian parasites (English)

1 reference

28 July 2017

main subject

Cryptosporidium parvum

object named as

Cryptosporidium parvum

1 reference

Coombs GH

1

1 reference

28 July 2017

publication date

1 August 1999

1 reference

28 July 2017

published in

Trends in Parasitology

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

8

1 reference

28 July 2017

page(s)

333-338

1 reference

Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Cryptosporidium and cryptosporidiosis in man and animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Chemotherapy of human and animal coccidioses: state and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Biochemistry of the coccidia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Ultrastructural analysis of the sporozoite of Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Some phosphonic acid analogs as inhibitors of pyrophosphate-dependent phosphofructokinase, a novel target in Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

A bradyzoite stage-specifically expressed gene of Toxoplasma gondii encodes a polypeptide homologous to lactate dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

The mannitol cycle--a new metabolic pathway in the Coccidia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Evidence for and characterization of a mannitol cycle in Eimeria tenella

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

14-3-3 and its possible role in co-ordinating multiple signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Molecular cloning and functional expression of mannitol-1-phosphatase from the apicomplexan parasite Eimeria tenella

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Apicidins: Novel cyclic tetrapeptides as coccidiostats and antimalarial agents from Fusarium pallidoroseum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Anticryptosporidial activity is associated with specific sulfonamides in immunosuppressed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Management of toxoplasmosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Plastid in human parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

A plastid of probable green algal origin in Apicomplexan parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

The apicoplast as a potential therapeutic target in and other apicomplexan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

A plastid organelle as a drug target in apicomplexan parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Optical and radiocarbon dating at Jinmium rock shelter in northern Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Shikimate pathway in apicomplexan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Shikimate pathway in apicomplexan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Amino acid biosynthesis inhibitors as herbicides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

(6S)-6-fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Synthesis of 2-Bromo- and 2-Fluoro-3-dehydroshikimic Acids and 2-Bromo- and 2-Fluoroshikimic Acids Using Synthetic and Enzymatic Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Mode of anticoccidal action of arprinocid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Hypoxanthine, guanine, xanthine phosphoribosyltransferase activity in Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Enzymes of parasite thiol metabolism as drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

Cryptosporidiosis: laboratory investigations and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901474-X

7 January 2021

10.1016/S0169-4758(99)01474-X

Identifiers

DOI

1 reference

28 July 2017

1 reference